HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ashley Yeo

Executive Editor, MTI; Medtech Editor, In Vivo

London, UK

Ashley has reported on health care market issues with Citeline and legacy companies since 1988, initially as a linguist on the France and Germany desk and later becoming editor of three titles. Two publications are his current focus for written and multimedia (panel moderating and podcasts) content: In Vivo (global medtech market access); and Medtech Insight (regulation and policy content for the UK, European and Asia markets).

Latest From Ashley Yeo

On-Prescription Apps Are Just One Vital Part Of Germany’s Digital Strategy

Are too few digital health care apps approved for reimbursement in Germany? That’s not the point, says the health care ministry, urging a look at the bigger strategic picture.

Germany Digital Health

Swiss Parliament’s Vote For Medtech Innovation Succeeds

Another key stage has been reached in Switzerland’s bid to enable US FDA-approved medtech to be used in the local population.

Switzerland Regulation

German Digital Health Strategy And EPR Project Get A Reboot

Digitization of the German health care system has been slow to get going, as the health ministry readily admits. A fresh start should bring different results, the ministry’s head of e-health Sebastian Zilch told Medica attendees.

Germany Policy

UK Medtech Strategy Before 2022 Year End, Government Promises

The UK government’s new procurement-and-beyond body housed in the DHSC says a medtech strategy could hit the presses before 2023. The medtech industry is cheered by promises of engagement.

United Kingdom Policy

Mike Mussallem: Inspiring People Is A Way Of Life

Edwards Lifesciences CEO Mike Mussallem has a unique and long-standing perspective of what the medtech industry should be and do. In over two decades, he has built the structural heart disease and critical care monitoring company into one of the global medtech industry’s most effective innovators.

Medical Device Outlook 2023

Why Patient-Centered Care Has To Change

A typical word cloud for discussions around patient-centered care would feature: business model, digital health, financing, PPP, resources, data sharing, staffing and escalation of costs. But so many other words are missing, which is why patient-centricity risks getting stuck in its current incomplete form. What are medtechs to do?

Medical Device Outlook 2023
See All
UsernamePublicRestriction

Register